We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

00088K:KRXHanwha Corporation Analysis

Data as of 2026-03-15 - not real-time

₩49,050.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Hanwha Corp (00088K) is trading at KRW 49,050, just below its 20‑day SMA of 49,720 but comfortably above the 50‑day SMA (46,976) and well over the 200‑day SMA (39,543). The stock sits near the identified support level of 44,450 with resistance at 58,800, and while the overall trend is flagged as bullish, technical momentum is mixed: the MACD histogram is negative (bearish signal) and the RSI hovers around 50, suggesting a neutral stance. Volume is increasing and the 30‑day volatility is high at roughly 75%, though the beta of 0.47 points to lower systematic risk relative to the market.
Fundamentally, the company shows strong top‑line momentum with a 45.6% revenue growth rate, a dividend yield of 2.34% supported by a modest payout ratio (~6%). However, profitability is thin (profit margin ~1.7%) and leverage is high (debt‑to‑equity ~133). The DCF‑derived fair value of about KRW 323,859 suggests the stock is significantly undervalued, but the high debt load and modest returns (ROE ~9%) temper optimism.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD histogram indicating short‑term momentum weakness
  • Price below 20‑day SMA suggesting limited upside
  • High 30‑day volatility increasing near‑term risk

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Robust 45% YoY revenue growth
  • DCF fair value far exceeds current market price
  • Sustainable dividend yield with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Diversified conglomerate business model across multiple industries
  • Strong cash position relative to debt providing financial flexibility
  • Commitment to dividend payments supporting shareholder returns

Key Metrics & Analysis

Financial Health

Revenue Growth45.60%
Profit Margin1.74%
ROE8.91%
ROA1.21%
Debt/Equity133.08
Op. Cash Flow₩9598.8B
Free Cash Flow₩1434.6B
Industry P/E29.1

Technical Analysis

TrendBullish
RSI50.1
Support₩44,450.00
Resistance₩58,800.00
MA 20₩49,720.00
MA 50₩46,976.00
MA 200₩39,543.25
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair Value₩323,859.44
GradeUndervalued
TypeGrowth
Dividend Yield2.34%

Risk Assessment

Beta0.47
Volatility75.51%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.